-
Company Insights
Innovation and Patenting activity of OliX Pharmaceuticals Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of OliX Pharmaceuticals Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Thematic Analysis
NewRNA-Based Drugs and the Impact of COVID-19
This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements within the pharmaceutical industry in reference to RNA technology is provided, allowing you to identify and discern the key points within this area.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OLX-75016 in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OLX-75016 in Liver Cirrhosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OLX-75016 in Liver Cirrhosis Drug Details: OLX-702A is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OLX-75016 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OLX-75016 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OLX-75016 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: OLX-702A...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OLX-75016 in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OLX-75016 in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OLX-75016 in Metabolic Dysfunction-Associated Steatotic Liver Disease...
-
Product Insights
Hypertrophic Scars – Drugs In Development, 2023
Global Markets Direct’s, ‘Hypertrophic Scars - Drugs In Development, 2023’, provides an overview of the Hypertrophic Scars pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hypertrophic Scars, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Androgenic Alopecia – Drugs In Development, 2023
Global Markets Direct’s, ‘Androgenic Alopecia - Drugs In Development, 2023’, provides an overview of the Androgenic Alopecia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Androgenic Alopecia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...